Rapid Molecular Detection of Extrapulmonary Tuberculosis by the Automated GeneXpert MTB/RIF System
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
In total, 521 nonrespiratory specimens (91 urine, 30 gastric aspirate, 245 tissue, 113 pleural fluid, 19 cerebrospinal fluid [CSF], and 23 stool specimens) submitted to the German National Reference Laboratory for Mycobacteria (NRL) from May 2009 to August 2010 were comparatively investigated with the new molecular-based GeneXpert MTB/RIF (Xpert) assay system and conventional liquid and solid culture methods. Twenty (3.8%) of the 521 specimens gave no interpretable result. Whereas the sensitivity of the Xpert assay with tissue specimens was 69.0% (20 out of 29 culture-positive cases detected), 100% sensitivity was found with the urine and stool specimens. The combined sensitivity and specificity of the Xpert assay were calculated to be 77.3% and 98.2%, respectively.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“In a study from Germany, 6 of 10 tuberculous lymphadenitis cases confirmed by culture were detected by the newer GeneXpert test; 3 cases with positive results had negative culture results, but subsequent investigation suggested that these were true cases [36].”
From Current diagnosis and management of peripheral tuberculous lymphadenitis. (2011) · cites this paper as [36]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source doesn’t support the claim as written.
In the citing paper
“Previous studies reported 98–100% agreement in detection of rifampicin resistance strains using the Xpert test and phenotypic drug susceptibility test [13,14,18,26].”
From GeneXpert MTB/RIF Assay for the Diagnosis of Tuberculous Lymphadenitis on Concentrated Fine Needle Aspirates in High Tuberculosis Burden Settings (2015) · cites this paper as [14]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The various clinical presentations of EPTB are non-specific, and the disease is often paucibacillary leading to low sensitivities of routine diagnostic methods such as; acid-fast bacilli (AFB) microscopy [1–3] and culture [1, 4, 5].”
From MPT64 antigen detection test improves routine diagnosis of extrapulmonary tuberculosis in a low-resource setting: A study from the tertiary care hospital in Zanzibar (2018) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In that study, the combined sensitivity and specificity of 77.3% and 98.2% were reported, respectively.”
From Xpert MTB/RIF for Rapid Diagnosis of Tuberculous Lymphadenitis from Fine-Needle-Aspiration Biopsy Specimens (2011) · cites this paper as [6]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Xpert® MTB/RIF (Cepheid, Sunnyvale, USA) is an automated, cartridge-based NAAT for the detection of M. tuberculosis complex and rifampicin drug-resistance from sputum and other specimens, with a turnaround time of less than two hours [19, 20].”
From Evaluation of Xpert® MTB/RIF and Ustar EasyNAT™ TB IAD for diagnosis of tuberculous lymphadenitis of children in Tanzania: a prospective descriptive study (2016) · cites this paper as [20]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rapid Molecular Detection of Tuberculosis and Rifampin Resistance
Boehme, C. C., Nabeta, P., Hillemann, D., Nicol, M. P., Shenai, S., Krapp, F., Allen, J., Tahirli, R., Blakemore, R., Rustomjee, R., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907847 · Cited by 2,309 · cited 3×
“Molecular techniques have substantially changed the field of tuberculosis diagnosis and have been proven to yield rapid results while being highly sensitive (2).”
BackgroundInfluentialSelf-citationHelb, D., Jones, M., Story, E., Boehme, C., Wallace, E., Ho, K., Kop, J., Owens, M. R., Rodgers, R., Banada, P., et al. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01463-09 · Cited by 914 · cited 1×
“The Xpert assay was performed as recently described (11).”
MethodSelf-citationGlobal epidemiology of tuberculosis
Dye, C. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68384-0 · Cited by 716
Hillemann, D., Rüsch-Gerdes, S., & Richter, E. (2007) · Journal of Clinical Microbiology · doi:10.1128/jcm.00521-07 · Cited by 345 · cited 1×
“Furthermore, sequencing showed an rpoB mutation in codon 533, resulting in a lysine-to-proline exchange, whose association with RMP resistance is debated (12, 15, 19).”
BackgroundSelf-citationTelenti, A., Honoré, N., Bernasconi, C., March, J., Ortega, A., Heym, B., Takiff, H. E., & Cole, S. T. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.3.719-723.1997 · Cited by 320 · cited 1×
“In all discordant cases, the 81-bp rpoB hot-spot region of culture isolates was analyzed by PCR and DNA sequencing with primers TR8 and TR9 to identify the presence or absence of rpoB core mutations (20).”
MethodLing, D. I., Flores, L. L., Riley, L. W., & Pai, M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001536 · Cited by 222
El-Hajj, H. H., Marras, S. A. E., Tyagi, S., Kramer, F. R., & Alland, D. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.11.4131-4137.2001 · Cited by 180 · cited 1×
“To determine rifampin (RMP) resistance, the rifampin resistance-determining region of the rpoB gene is probed with molecular beacons (7).”
BackgroundRifampicin resistance and mutation of the rpoB gene in Mycobacterium tuberculosis
Taniguchi, H., Aramaki, H., Nikaido, Y., Mizuguchi, Y., Nakamura, M., Koga, T., & Yoshida, S.-I. (1996) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1996.tb08515.x · Cited by 154 · cited 4×
“These comprised 91 urine, 30 gastric aspirate, 245 tissue, 113 pleural fluid, 19 cerebrospinal fluid (CSF), and 23 stool specimens.”
BackgroundInfluentialRichter, E., Rüsch–Gerdes, S., & Hillemann, D. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.5.1769-1775.2006 · Cited by 146 · cited 1×
“For the identification of MTBC organisms and the differentiation of MTBC and NTM from positive cultures, two commercially available DNA strip assays were used, the GenoType MTBC and CM/AS assays (Hain Lifescience GmbH, Nehren, Germany) (17, 18).”
MethodSelf-citationTechnology for Automated, Rapid, and Quantitative PCR or Reverse Transcription-PCR Clinical Testing
Raja, S., Ching, J., Xi, L., Hughes, S. J., Chang, R., Wong, W., McMillan, W., Gooding, W. E., McCarty, K. S., Chestney, M., et al. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2004.046474 · Cited by 136 · cited 1×
“The test runs on the GeneXpert platform (Cepheid, Sunnyvale, CA) using a disposable plastic cartridge with all required reagents (16).”
Method
Cited by
Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults
Steingart, K. R., Schiller, I., Horne, D. J., Pai, M., Boehme, C. C., & Dendukuri, N. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009593.pub3 · Cited by 1,102
Self-citationDenkinger, C. M., Schumacher, S. G., Boehme, C. C., Dendukuri, N., Pai, M., & Steingart, K. R. (2014) · European Respiratory Journal · doi:10.1183/09031936.00007814 · Cited by 527
Self-citationLawn, S. D., & Nicol, M. P. (2011) · Future Microbiology · doi:10.2217/fmb.11.84 · Cited by 486
“assessed the utility of Xpert for TB diagnosis in nonrespiratory samples, including pleural fluid, gastric fluid, tissue, cerebrospinal fluid, urine and stool [25,31,32].”
BackgroundResultLawn, S. D., Mwaba, P., Bates, M., Piatek, A., Alexander, H., Marais, B. J., Cuevas, L. E., McHugh, T. D., Zijenah, L., Kapata, N., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70008-2 · Cited by 458
Clinical validation of Xpert MTB/RIF for the diagnosis of extrapulmonary tuberculosis
Tortoli, E., Russo, C., Piersimoni, C., Mazzola, E., Dal Monte, P., Pascarella, M., Borroni, E., Mondo, A., Piana, F., Scarparo, C., et al. (2012) · European Respiratory Journal · doi:10.1183/09031936.00176311 · Cited by 322
“The first study [11], similar to ours for the epidemiological background, omitted in the evaluation the clinical diagnosis, while the other [12] was carried out in a high prevalence TB country.”
ResultRapid and Fully Microfluidic Ebola Virus Detection with CRISPR-Cas13a
Qin, P., Park, M., Alfson, K. J., Tamhankar, M., Carrion, R., Patterson, J. L., Griffiths, A., He, Q., Yildiz, A., Mathies, R., et al. (2019) · ACS Sensors · doi:10.1021/acssensors.9b00239 · Cited by 311
Current diagnosis and management of peripheral tuberculous lymphadenitis.
Fontanilla, J.-M., Barnes, A., & von Reyn, C. F. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir454 · Cited by 299
Lawn, S. D., Brooks, S. V., Kranzer, K., Nicol, M. P., Whitelaw, A., Vogt, M., Bekker, L.-G., & Wood, R. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001067 · Cited by 278
Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults
Horne, D. J., Kohli, M., Zifodya, J. S., Schiller, I., Dendukuri, N., Tollefson, D., Schumacher, S. G., Ochodo, E. A., Pai, M., & Steingart, K. R. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009593.pub4 · Cited by 267
“…and children or no information about age of enrolment Hanifa 2016 Reference standard not satisfied Heidebrecht 2016 Data insufficient for 2 x 2 table Hillemann 2011 This study evaluated Xpert MTB/RIF for the diagnosis of extrapulmonary TB Hiza 2017 Not a diagnostic accuracy study Ho 2016…”
MethodChang, K., Lu, W., Wang, J., Zhang, K., Jia, S., Li, F., Deng, S., & Chen, M. (2012) · Journal of Infection · doi:10.1016/j.jinf.2012.02.012 · Cited by 267
Rapid molecular TB diagnosis: evidence, policy making and global implementation of Xpert MTB/RIF
Weyer, K., Mirzayev, F., Migliori, G. B., Van Gemert, W., D'Ambrosio, L., Zignol, M., Floyd, K., Centis, R., Cirillo, D. M., Tortoli, E., et al. (2013) · European Respiratory Journal · doi:10.1183/09031936.00157212 · Cited by 256
Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults
Steingart, K. R., Sohn, H., Schiller, I., Kloda, L. A., Boehme, C. C., Pai, M., & Dendukuri, N. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009593.pub2 · Cited by 253
Self-citationXpert ® MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance
Kohli, M., Schiller, I., Dendukuri, N., Dheda, K., Denkinger, C. M., Schumacher, S. G., & Steingart, K. R. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012768.pub2 · Cited by 245
Drug‐resistant tuberculosis: An update on disease burden, diagnosis and treatment
Lange, C., Chesov, D., Heyckendorf, J., Leung, C. C., Udwadia, Z., & Dheda, K. (2018) · Respirology · doi:10.1111/resp.13304 · Cited by 244
Evaluation of GeneXpert MTB/RIF for Diagnosis of Tuberculous Meningitis
Nhu, N. T. Q., Heemskerk, D., Thu, D. D. A., Chau, T. T. H., Mai, N. T. H., Nghia, H. D. T., Loc, P. P., Ha, D. T. M., Merson, L., Thinh, T. T. V., et al. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.01834-13 · Cited by 244
Lawn, S. D. (2012) · BMC Infectious Diseases · doi:10.1186/1471-2334-12-103 · Cited by 242
“Fine needle aspirates of enlarged lymph nodes and urine samples [25,43,45,46] might also be examined using culture or the Xpert MTB/RIF assay and mycobacterial blood cultures might be done to provide a composite microbiological gold standard.”
MethodMaynard-Smith, L., Larke, N., Peters, J. A., & Lawn, S. D. (2014) · BMC Infectious Diseases · doi:10.1186/s12879-014-0709-7 · Cited by 218
“text review, 55 papers were subsequently excluded, and 31 papers containing data on the diagnostic accuracy of Xpert MTB/RIF for TB when testing non-respiratory samples were reviewed in detail [12-38].”
BackgroundKohli, M., Schiller, I., Dendukuri, N., Yao, M., Dheda, K., Denkinger, C. M., Schumacher, S. G., & Steingart, K. R. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012768.pub3 · Cited by 215
Diagnosis of extrapulmonary tuberculosis by PCR
Mehta, P. K., Raj, A., Singh, N., & Khuller, G. K. (2012) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2012.00987.x · Cited by 194
“Considering culture as the gold standard, similar encouraging results have been observed by Hillemann et al. (2011) for TB identification in 512 EPTB specimens.”
BackgroundMethodResultInfluentialZifodya, J. S., Kreniske, J. S., Schiller, I., Kohli, M., Dendukuri, N., Schumacher, S. G., Ochodo, E. A., Haraka, F., Zwerling, A. A., Pai, M., et al. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009593.pub5 · Cited by 179
Armand, S., Vanhuls, P., Delcroix, G., Courcol, R., & Lemaître, N. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02157-10 · Cited by 179
“have also recently reported a lower sensitivity of the Xpert MTB/RIF test with tissue specimens and suggested a preincubation step with proteinase K (10).”
BackgroundPatel, V. B., Theron, G., Lenders, L., Matinyena, B., Connolly, C., Singh, R., Coovadia, Y., Ndung'u, T., & Dheda, K. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001536 · Cited by 179
“Published data include only small numbers of microbiologically proven TBM cases (range of 0 to 23) [29–32], often in a case-control design with a non-uniform reference standard, and often CSF-associated data were published as part of a laboratory-based evaluation of extrapulmonary TB samples, usually including samples…”
BackgroundScott, L. E., McCarthy, K., Gous, N., Nduna, M., Van Rie, A., Sanne, I., Venter, W. F., Duse, A., & Stevens, W. (2011) · PLoS Medicine · doi:10.1371/journal.pmed.1001061 · Cited by 171
“7% for tissue specimens and up to 100% in urine and stool specimens [17,18].”
BackgroundDifferential diagnosis of inflammatory bowel disease: imitations and complications
Gecse, K. B., & Vermeire, S. (2018) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(18)30159-6 · Cited by 161
Rachow, A., Zumla, A., Heinrich, N., Rojas-Ponce, G., Mtafya, B., Reither, K., Ntinginya, E. N., O'Grady, J., Huggett, J., Dheda, K., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020458 · Cited by 160
Self-citationHickey, A. J., Gounder, L., Moosa, M. S., & Drain, P. K. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-0944-6 · Cited by 154
“The Xpert MTB/RIF assay has been approved for diagnosing pulmonary TB from sputum samples and is being evaluated for diagnostic accuracy in extrapulmonary tissues, including liver [66,67].”
MethodIoannidis, P., Papaventsis, D., Karabela, S., Nikolaou, S., Panagi, M., Raftopoulou, E., Konstantinidou, E., Marinou, I., & Kanavaki, S. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00718-11 · Cited by 153
“Discrepancies between Xpert MTB/RIF and DST results regarding rifampin resistance (false resistance or false sensitivity) have also been reported previously (2, 5, 6).”
MethodResultRufai, S. B., Kumar, P., Singh, A., Prajapati, S., Balooni, V., & Singh, S. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.03005-13 · Cited by 148
Etiology and management of genitourinary tuberculosis
Abbara, A., & Davidson, R. N. (2011) · Nature Reviews Urology · doi:10.1038/nrurol.2011.172 · Cited by 140
Sehgal, I. S., Dhooria, S., Aggarwal, A. N., Behera, D., & Agarwal, R. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.03205-15 · Cited by 134
Heller, T., Wallrauch, C., Goblirsch, S., & Brunetti, E. (2012) · The Ultrasound Journal · doi:10.1186/2036-7902-4-21 · Cited by 132
“The roll-out of new technologies like the GeneXpert MTB in South Africa is promising as its technology might also be used on non-respiratory samples [15]; whether this will change the diagnostic approach cannot be concluded yet as data on its sensitivity and specificity in pericardial effusions is still lacking.”
BackgroundXpert MTB/RIF Assay for Diagnosis of Pleural Tuberculosis
Friedrich, S. O., von Groote-Bidlingmaier, F., & Diacon, A. H. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.05454-11 · Cited by 126
“(8) found 3 positive Xpert results out”
Brancusi, F., Farrar, J., & Heemskerk, D. (2012) · Future Microbiology · doi:10.2217/fmb.12.86 · Cited by 142
“2%, respectively [71].”
Ligthelm, L. J., Nicol, M. P., Hoek, K. G. P., Jacobson, R., van Helden, P. D., Marais, B. J., Warren, R. M., & Wright, C. A. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.01310-11 · Cited by 123
“Xpert MTB/RIF has been used successfully on various extrapulmonary specimens, including urine and stool (6), but has not been rigorously evaluated with the use of tissue specimens, such as FNAB specimens.”
BackgroundMethodDiagnosis of extrapulmonary tuberculosis using the Xpert®MTB/RIF assay
Lawn, S. D., & Zumla, A. I. (2012) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.12.43 · Cited by 127
“It represents the largest number of nonrespiratory samples tested with Xpert MTB/RIF of any study published to date and provides a much larger number of EPTB diagnoses compared with most other studies, with the exception of the study from India by Vadwai and colleagues (Table 1) [6–12].”
ResultTheron, G., Peter, J., Calligaro, G., Meldau, R., Hanrahan, C., Khalfey, H., Matinyenya, B., Muchinga, T., Smith, L., Pandie, S., et al. (2014) · Scientific Reports · doi:10.1038/srep05658 · Cited by 121
A multisite assessment of the quantitative capabilities of the Xpert MTB/RIF assay
Blakemore, R., Nabeta, P., Davidow, A. L., Vadwai, V., Tahirli, R., Munsamy, V., Nicol, M., Jones, M., Persing, D. H., Hillemann, D., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201103-0536oc · Cited by 118
Self-citationBarnard, M., van Pittius, N. C. G., van Helden, P. D., Bosman, M. E., Coetzee, G. J., & Warren, R. M. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.01958-12 · Cited by 116
“1%, respectively, and similar specificities of 100%, which compared well with previous studies using the Xpert MTB/RIF (5, 8, 11).”
ResultScott, L. E., Beylis, N., Nicol, M., Nkuna, G., Molapo, S., Berrie, L., Duse, A., & Stevens, W. S. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.03553-13 · Cited by 114
Improved diagnostic sensitivity for tuberculous meningitis with Xpert® MTB/RIF of centrifuged CSF
Bahr, N. C., Tugume, L., Rajasingham, R., Kiggundu, R., Williams, D. A., Morawski, B., Alland, D., Meya, D. B., Rhein, J., & Boulware, D. R. (2015) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.15.0253 · Cited by 113
Epidemiology of extrapulmonary tuberculosis in Brazil: a hierarchical model
Gomes, T., Reis-Santos, B., Bertolde, A. I., Johnson, J. L., Riley, L. W., & Maciel, E. L. N. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-9 · Cited by 107
“In Brazil this result may be related to easier access to diagnostic and health services among more educated individuals, given that the diagnosis of EPTB often requires invasive sampling procedures with additional expense and risk, and the collection of such samples is more difficult in public health services of resou…”
BackgroundEarly diagnosis of spinal tuberculosis
Chen, C., Chen, Y.-M., Lee, C.-W., Chang, Y., Cheng, C.-Y., & Hung, J.-K. (2016) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2016.07.001 · Cited by 118
Cost-Effective Diagnostic Checklists for Meningitis in Resource-Limited Settings
Durski, K. N., Kuntz, K. M., Yasukawa, K., Virnig, B. A., Meya, D. B., & Boulware, D. R. (2013) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31828e1e56 · Cited by 101
GeneXpert polymerase chain reaction for spinal tuberculosis
Held, M. F. G., Laubscher, M., Zar, H. J., & Dunn, R. N. (2014) · The Bone & Joint Journal · doi:10.1302/0301-620x.96b10.34048 · Cited by 103
Pandie, S., Peter, J. G., Kerbelker, Z. S., Meldau, R., Theron, G., Govender, U., Ntsekhe, M., Dheda, K., & Mayosi, B. M. (2014) · BMC Medicine · doi:10.1186/1741-7015-12-101 · Cited by 95
“Methods to further digest these proteins or the addition of a PCR-friendly blood lysis buffer may help to decrease error rates [31,32].”
BackgroundMoure, R., Martín, R., & Alcaide, F. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.06467-11 · Cited by 90
“The effectiveness of GX for diagnosing extrapulmonary TB has not been conclusively demonstrated, especially in countries with low or medium TB prevalence, since the system was initially validated only for respiratory specimens and most published studies include low numbers of extrapulmonary samples (1, 5, 9, 18).”
BackgroundPeter, J. G., Theron, G., Muchinga, T. E., Govender, U., & Dheda, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039966 · Cited by 89
“, in a selected laboratory cohort interrogating extra-pulmonary samples found that MTB/RIF sensitivity was 100% in 6 culture-positive urine samples with unknown HIV status [23], while Lawn et al, in HIVinfected out-patients pre-ARV initiation, report the overall sensitivity of urine MTB/RIF to be 19% [24].”
BackgroundCohen, L. A., & Light, R. W. (2015) · Turkish Thoracic Journal · doi:10.5152/ttd.2014.001 · Cited by 112
Tadesse, M., Abebe, G., Abdissa, K., Aragaw, D., Abdella, K., Bekele, A., Bezabih, M., Apers, L., de Jong, B. C., & Rigouts, L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0137471 · Cited by 85
Key Enabling Technologies for Point-of-Care Diagnostics
Primiceri, E., Chiriacò, M. S., Notarangelo, F. M., Crocamo, A., Ardissino, D., Cereda, M., Bramanti, A. P., Bianchessi, M. A., Giannelli, G., & Maruccio, G. (2018) · Sensors · doi:10.3390/s18113607 · Cited by 94
“The reactions take place on a disposable cartridge, including a sample preparation system, so that the instrument manages an entire sample-to-answer flow, for the supported assays [91,92].”
BackgroundCRISPR-Cas13: A new technology for the rapid detection of pathogenic microorganisms
Huang, Z., Fang, J., Zhou, M., Gong, Z., & Xiang, T. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1011399 · Cited by 94
“, 2018), and it has become the gold standard for nucleic acid detection (Saiki et al., 1985; Hillemann et al., 2011).”
BackgroundMiller, M. B., Popowitch, E. B., Backlund, M. G., & Ager, E. P. C. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.05212-11 · Cited by 77
“Pulmonary Bronchial brush (1), bronchial wash (5), bronchoalveolar lavage (11), expectorated sputum (24), induced sputum (17), lung biopsy specimen (4), nasopharyngeal aspirate (1), pleural fluid (2), sputum (unspecified) (3), tracheal aspirate (2) Bronchial wash specimen (1), bronchoalveolar lavage fluid (3), expecto…”
BackgroundMeldau, R., Peter, J., Theron, G., Calligaro, G., Allwood, B., Symons, G., Khalfey, H., Ntombenhle, G., Govender, U., Binder, A., et al. (2014) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-14-58 · Cited by 75
“However, there are limited data about the Xpert MTB/RIF assay using pleural fluid [10-17] and thus the usefulness of this assay in the context of pleural TB remains unclear.”
BackgroundMethodWood, R., Racow, K., Bekker, L., Middelkoop, K., Vogt, M., Kreiswirth, B. N., & Lawn, S. D. (2012) · BMC Infectious Diseases · doi:10.1186/1471-2334-12-47 · Cited by 75
“Median age years [IQR] 34 [28-43] 35 [30-40] 34 [28-44] 0.”
Epidemiology of Meningitis in an HIV-Infected Ugandan Cohort
Rajasingham, R., Rhein, J., Klammer, K., Musubire, A., Nabeta, H., Akampurira, A., Mossel, E. C., Williams, D. A., Boxrud, D. J., Crabtree, M. B., et al. (2015) · The American Society of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.14-0452 · Cited by 74
Diagnosis of smear-negative tuberculosis is greatly improved by Xpert MTB/RIF
Lombardi, G., Gregori, V. D., Girometti, N., Tadolini, M., Bisognin, F., & Monte, P. D. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176186 · Cited by 89
Perspectives on Introduction and Implementation of New Point-of-Care Diagnostic Tests
Palamountain, K. M., Baker, J. M., Cowan, E. P., Essajee, S. M., Mazzola, L. T., Metzler, M., Schito, M. L., Stevens, W. S., Young, G. J., & Domingo, G. J. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis203 · Cited by 71
Diagnosis of lymph node tuberculosis using the GeneXpert MTB/RIF in Tunisia
Ghariani, A., Jaouadi, T., Smaoui, S., Mehiri, E., Marouane, C., Kammoun, S., Essalah, L., Driss, M., Messadi, F., & Slim-Saidi, L. (2015) · International Journal of Mycobacteriology · doi:10.1016/j.ijmyco.2015.05.011 · Cited by 65
“All strains were found to be susceptible to RIF in both Xpert method and conventional drug susceptibility testing [12,13].”
MethodDiagnosing tuberculous meningitis – have we made any progress?
Ho, J., Marais, B. J., Gilbert, G. L., & Ralph, A. P. (2013) · Tropical Medicine & International Health · doi:10.1111/tmi.12099 · Cited by 65
Rapid diagnosis of tuberculosis using Xpert MTB/RIF assay - Report from a developing country
Yusuf, N. W., Iram, S., Zeenat, A., Hussain, S., & Aslam, M. (2014) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.311.6970 · Cited by 73
REVIEW ARTICLES Genitourinary tuberculosis: historical and basic science review: past and present
Zajaczkowski, T. (2012) · Editor-in-Chief s Voice List of Authors is an Important Element in a Scientific Publication · doi:10.5173/ceju.2012.04.art1 · Cited by 63
Allahyartorkaman, M., Mirsaeidi, M. S., Hamzehloo, G., Amini, S., Zakiloo, M., & Nasiri, M. J. (2019) · Scientific Reports · doi:10.1038/s41598-019-55112-y · Cited by 68
Banada, P. P., Naidoo, U., Deshpande, S., Karim, F., Flynn, J. L., O’Malley, M., Jones, M., Nanassy, O. Z., Jeena, P. M., & Alland, D. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151980 · Cited by 71
“Xpert stool tests also generated unacceptably large numbers of errors (13–25%) [22, 26], probably from sample clogging the Xpert assay cartridge or due to PCR inhibition from stool components.”
BackgroundMethodResultStool Culture for Diagnosis of Pulmonary Tuberculosis in Children
Walters, E. G., Demers, A., van der Zalm, M. M., Whitelaw, A. C., Palmer, M., Bosch, C., Draper, H. R., Gie, R. P., & Hesseling, A. C. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.00801-17 · Cited by 66
“The other published pediatric stool culture studies do not report on contamination rates, but studies in adults using MGIT report 14 to 38% contaminated cultures (23, 33, 34).”
BackgroundChaidir, L., Ganiem, A. R., vander Zanden, A., Muhsinin, S., Kusumaningrum, T., Kusumadewi, I., van der Ven, A., Alisjahbana, B., Parwati, I., & van Crevel, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052001 · Cited by 61
“lower sensitivity compared to culture, but to our knowledge only one study has reported use in suspected meningitis [9].”
BackgroundRufai, S. B., Singh, A., Singh, J., Kumar, P., Sankar, M. M., Singh, S., Nigam, K. P., Sharma, D., Gupta, A. K., & Rawat, V. S. (2017) · Journal of Infection · doi:10.1016/j.jinf.2017.04.010 · Cited by 61
Geake, J. B., Hammerschlag, G., Nguyen, P., Wallbridge, P. D., Jenkin, G., Korman, T. M., Jennings, B. R., Johnson, D. F., Irving, L. B., Farmer, M. W., et al. (2015) · PubMed Central · doi:10.3978/j.issn.2072-1439.2015.01.33 · Cited by 64
“Recent studies suggest that GeneXpert PCR may have superior sensitivity and specificity for the diagnosis of TB, although its use has not been validated for extra-pulmonary samples (45-48).”
BackgroundSali, M., Maio, F. D., Caccuri, F., Campilongo, F., Sanguinetti, M., Fiorentini, S., Delogu, G., & Giagulli, C. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.01904-15 · Cited by 59
“232 Extra-pulmonary TB can be challenging to diagnose since the number of bacteria in these 233 specimens is often low because of the paucibacillary nature of the disease (19).”
BackgroundHuang, E., Wang, Y., Yang, N., Shu, B., Zhang, G., & Liu, D. (2021) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-021-03171-4 · Cited by 59
“This type of microfluidic chip systems effectively extends the throughput, but their application is still limited to specialized laboratories due to the absence of sample preparation; (2) integrated microfluidic device with a single reactor, represented by the GeneXpert system [35].”
MethodRajagopalan, S. (2016) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2016.02.006 · Cited by 61
Dhasmana, D. J., Ross, C., Bradley, C. J., Connell, D. W., George, P. M., Singanayagam, A., Jepson, A., Craig, C., Wright, C., Molyneaux, P. L., et al. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201308-250oc · Cited by 57
Shenai, S., Amisano, D., Ronacher, K., Kriel, M., Banada, P. P., Song, T., Lee, M., Joh, J.-S., Winter, J. A., Thayer, R., et al. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.01743-13 · Cited by 65
“unknown HIV status (36) and from patients who are known to be”
BackgroundArdizzoni, E., Fajardo, E., Saranchuk, P., Casenghi, M., Page, A., Varaine, F., Kosack, C., & Hepple, P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144656 · Cited by 61
“[2] The Xpert test is an automated molecular system that allows for rapid, simultaneous detection of bothMycobacterium tuberculosis (MTB) and resistance to rifampicin, a key first-line anti-TB drug, directly from sputum [3] and extrapulmonary samples.[4] In 2010, the World Health Organization (WHO) endorsed the Xpert…”
MethodRapid diagnostic tests for neurological infections in central Africa
Yansouni, C. P., Bottieau, E., Lutumba, P. T., Winkler, A. S., Lynen, L., Büscher, P., Jacobs, J. A., Gillet, P., Lejon, V., Alirol, E., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70004-5 · Cited by 57
Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: a diagnostic evaluation study
Tadesse, M., Abebe, G., Bekele, A., Bezabih, M., Yilma, D., Apers, L., de Jong, B. C., & Rigouts, L. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.12.018 · Cited by 55
The validity of cerebrospinal fluid parameters for the diagnosis of tuberculous meningitis
Solari, L., Soto, A., Agapito, J., Acurio, V., Vargas, D., Battaglioli, T., Accinelli, R. A., Gotuzzo, E., & der Stuyft, P. V. (2013) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2013.06.003 · Cited by 54
Du, J., Huang, Z., Luo, Q., Xiong, G., Xu, X., Li, W., Liu, X., & Li, J. (2015) · PubMed Central · Cited by 54
Altez-Fernandez, C., Ortiz-Soriano, V., Mirzazadeh, M., Zegarra, L., Seas, C., & Ugarte‐Gil, C. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2476-8 · Cited by 55
Reducing deaths from tuberculosis in antiretroviral treatment programmes in sub-Saharan Africa
Lawn, S. D., Harries, A. D., Meintjes, G., Getahun, H., Havlir, D. V., & Wood, R. (2012) · AIDS · doi:10.1097/qad.0b013e3283565dd1 · Cited by 55
“Testing fine needle aspirates of lymph nodes and other extrapulmonary clinical samples using Xpert might be used to further increase diagnostic yield in HIVinfected patients [60–63].”
MethodBabafemi, E. O., Cherian, B. P., Banting, L., Mills, G. A., & Kandala, N.-B. (2017) · Systematic Reviews · doi:10.1186/s13643-017-0608-2 · Cited by 56
“Hillemann, 2011 [42] Germany – 521 MGIT 960 LJ GenoType MTBC and CM/AS assays (Hain Lifescience) rpoB probe”
MethodBansal, R., Sharma, K., Gupta, A., Sharma, A., Singh, M. P., Gupta, V., Mulkutkar, S., Dogra, M., Dogra, M. R., Kamal, S., et al. (2015) · Ophthalmology · doi:10.1016/j.ophtha.2014.11.021 · Cited by 53
Bunsow, E., Ruiz‐Serrano, M. J., López-Roa, P., Kestler, M., de Viedma, D. G., & Bouza, E. (2013) · Journal of Infection · doi:10.1016/j.jinf.2013.11.012 · Cited by 54
Yu, G., Zhong, F., Ye, B., Xu, X., Chen, D., & Shen, Y. (2019) · BioMed Research International · doi:10.1155/2019/4878240 · Cited by 52
Lawn, S. D., Kerkhoff, A. D., Vogt, M., & Wood, R. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318258c6af · Cited by 51
“However, there are also reports of Xpert being used to diagnose TB by testing a range of extrapulmonary samples, including urine.(17,18) In this study, we therefore determined the diagnostic sensitivity of Xpert MTB/RIF when testing small volumes of urine obtained from HIV-infected patients being screened for TB befor…”
Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
Bodmer, T., & Ströhle, A. (2012) · Journal of Visualized Experiments · doi:10.3791/3547 · Cited by 51
“Data on the assay's performance when testing extra-pulmonary TB is emerging.(15)”
BackgroundUpdate on tuberculosis: TB in the early 21st century
Connell, D. W., Berry, M. P. R., Cooke, G., & Kon, O. M. (2011) · European Respiratory Review · doi:10.1183/09059180.00000511 · Cited by 49
Al-Ateah, S. M., Al-Dowaidi, M. M., & El-Khizzi, N. A. (2012) · Saudi Medical Journal · doi:10.15537/1658-3175.5638 · Cited by 47
Salje, H., Andrews, J. R., Deo, S., Satyanarayana, S., Sun, A. Y., Pai, M., & Dowdy, D. W. (2014) · PLoS Medicine · doi:10.1371/journal.pmed.1001674 · Cited by 55
“25 [38,48–50]”
A novel aptamer-based test for the rapid and accurate diagnosis of pleural tuberculosis
Kumari, P., Lavania, S., Tyagi, S., Dhiman, A., Rath, D., Anthwal, D., Gupta, R. K., Sharma, N., Gadpayle, A. K., Taneja, R. S., et al. (2018) · Analytical Biochemistry · doi:10.1016/j.ab.2018.10.019 · Cited by 47
Solomons, R. S., Visser, D. H., Friedrich, S. O., Diacon, A. H., Hoek, K. G. P., Marais, B. J., Schoeman, J. F., & van Furth, A. M. (2015) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.14.0394 · Cited by 44
Epidemiology and Diagnosis of Tuberculous Lymphadenitis in a Tuberculosis Low-Burden Country
Salvador, F., Los-Arcos, I., Sánchez-Montalvá, A., Tórtola, T., Curran, A., Villar, A., Saborit, N., Castellví, J., & Molina, I. (2015) · Medicine · doi:10.1097/md.0000000000000509 · Cited by 43
Jørstad, M. D., Marijani, M., Dyrhol-Riise, A. M., Sviland, L., & Mustafa, T. (2018) · PloS one · doi:10.1371/journal.pone.0196723 · Cited by 43
Heyckendorf, J., Olaru, I. D., Rühwald, M., & Lange, C. G. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201402-0363pp · Cited by 46
“tuberculosis–specific nucleic acids can be isolated from different compartments, such as sputum and urine (33, 34).”
BackgroundPathogen-derived biomarkers for active tuberculosis diagnosis
Tucci, P., González‐Sapienza, G., & Marı́n, M. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00549 · Cited by 43
“This assay showed a high sensitivity in both pulmonary (Boehme et al., 2010) and extrapulmonary TB (Hillemann et al., 2011).”
BackgroundMethodInfluentialBaudel, J.-L., Tankovic, J., Dahoumane, R., Carrat, F., Galbois, A., Ait‐Oufella, H., Offenstadt, G., Guidet, B., & Maury, É. (2014) · Annals of Intensive Care · doi:10.1186/s13613-014-0035-7 · Cited by 45
“aureus, Mycobacterium tuberculosis, or Clostridium difficile [35-38]).”
Diagnostic accuracy of xpert test in tuberculosis detection: A systematic review and meta-analysis
Dang, A., Kaur, R., Kachroo, K., Sharma, J. K., & Vatturi, S. M. (2016) · Journal of Global Infectious Diseases · doi:10.4103/0974-777x.176143 · Cited by 43
Rahman, S. M. M., Maliha, U. T., Ahmed, S., Kabir, S., Khatun, R., Shah, J. A., & Banu, S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203063 · Cited by 49
Challenges in Pleural Tuberculosis Diagnosis: Existing Reference Standards and Nucleic Acid Tests
Tyagi, S., Sharma, N., Tyagi, J. S., & Haldar, S. (2017) · Future Microbiology · doi:10.2217/fmb-2017-0028 · Cited by 46
Houston, A., & Macallan, D. C. (2013) · Medicine · doi:10.1016/j.mpmed.2013.10.008 · Cited by 43
Molecular Approaches for Detection of the Multi-Drug Resistant Tuberculosis (MDR-TB) in Bangladesh
Aurin, T. H., Munshi, S. K., Kamal, S. M. M., Rahman, M. M., Hossain, M. S., Marma, T., Rahman, F., & Noor, R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099810 · Cited by 45
Metadata
- Authors
- Hillemann, D., Rüsch-Gerdes, S., Boehme, C., & Richter, E.
- Affiliations
- Research Center Borstel - Leibniz Lung Center (DE)
- Nationales Referenzzentrum für Mykobakterien, Forschungszentrum Borstel, Borstel, Germany
- FIND (CH)
- Corresponding author
- Hillemann, Doris
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2011-04
- Volume
- 49
- Issue
- 4
- Pages
- 1202-1205
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- PMC
- PMC3122824
- OpenAlex
- W2108234063
- Semantic Scholar
- 8a1ade3d18ad0c7efce7c5a71ea3d35d69eb764a
- Cited by
- 413
- References
- 18
- Citations by year
- 2026: 10 · 2025: 3 · 2024: 15 · 2023: 20 · 2022: 31 · 2021: 20 · 2020: 26 · 2019: 25 · 2018: 41 · 2017: 31 · 2016: 29 · 2015: 43 · 2014: 36 · 2013: 24 · 2012: 34
- FWCI
- 25.71
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Clinical Microbiology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Epidemiology › Mycobacterium research and diagnosis
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Keywords
- extrapulmonary tuberculosis, Xpert MTB/RIF, rapid molecular detection, Mycobacterium tuberculosis, sensitivity and specificity, urine samples, fecal samples, pleural fluid, cerebrospinal fluid, gastric aspirate, tissue samples, cultural comparison
- MeSH terms
- Automation, Bacteriological Techniques, Germany, Humans, Mycobacterium tuberculosis, Sensitivity and Specificity, Time Factors, Tuberculosis, Molecular Diagnostic Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.